| Trial ID: | L6284 |
| Source ID: | NCT06629688
|
| Associated Drug: |
Semaglutide
|
| Title: |
Semaglutide and Intestinal Iron Absorption
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2|Iron Absorption
|
| Interventions: |
DRUG: semaglutide
|
| Outcome Measures: |
Primary: General objective, Number of T2DM participant that will have reduction in intestinal iron absorption after the semaglutide administration, 10 weeks | Secondary: Specific objectives, Correlation between serum ferritin levels prior to the OIAT and the degree of iron absorption during semaglutide administration in patients with T2DM., 10 weeks | Other: Sex differences, Sex-dependent difference in intestinal iron absorption with the administration of semaglutide in patients with T2DM., 10 weeks
|
| Sponsor/Collaborators: |
Sponsor: University Hospital Dubrava
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
51
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-11-01
|
| Completion Date: |
2024-04-01
|
| Results First Posted: |
|
| Last Update Posted: |
2024-12-05
|
| Locations: |
University hospital Dubrava, Zagreb, 10000, Croatia
|
| URL: |
https://clinicaltrials.gov/show/NCT06629688
|
